Sucampo

Sucampo is committed to the development and commercialization of specialty pharmaceuticals that meet unmet medical needs for patients worldwide. Sucampo has two marketed products – its lead product AMITIZA and RESCULA – as well as a late-stage pipeline of clinical development candidates in the orphan disease area.